What we still don’t know about weight-loss drugs 🤯
No cap, MIT Technology Review Explains: Let our writers untangle the complex, messy world of technology to help you understand w...
The Tea ☕
No cap, MIT Technology Review Explains: Let our writers untangle the complex, messy world of technology to help you understand what’s coming next. You can read more from the series here.
Weight-loss drugs have been back in the news this week. First, we heard that Eli Lilly, the company behind the drugs Mounjaro and Zepbound, became the first healthcare… and it’s lowkey iconic.
What’s Actually Happening 👀
MIT Technology Review Explains: Let our writers untangle the complex, messy world of technology to help you understand what’s coming next.
The Vibe Check 💅
This whole situation is honestly giving main character energy. Whether you’re here for it or not, it’s definitely something to keep an eye on. Stay tuned bestie, we’ll keep you updated!
your fave news source that actually gets it 💕
Daily briefing
Get the next useful briefing
If this story was worth your time, the next one should be too. Get the daily briefing in one clean email.
Reader reaction